The Medicines Patent Pool signs licence with Bristol-Myers Squibb to increase access to hepatitis C medicine daclatasvir
The Medicines Patent Pool (MPP) has announced its first licence for a hepatitis C medicine, signing an agreement with Bristol-Myers Squibb for daclatasvir, a novel direct-acting antiviral that is...
Expensive drugs that cure hepatitis C are worth the cost, even at early stages of liver fibrosis
It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UC San Francisco study that...
Screening for Hep C in U.S. prisons is cost-effective, would benefit the general community
A computer model suggests that screening for hepatitis C virus (HCV) in U.S.
Platelets promote the liver's regeneration process following surgery
A team of researchers at the MedUni Vienna has discovered that certain platelet-derived growth factors are of major significance for the liver's regeneration processes.
Inflammation linked to weakened reward circuits in depression
Brain imaging shows distinctive aspects of high-inflammation depression.About one third of people with depression have high levels of inflammation markers in their blood.
Tumor-suppressor p53 regulates protein that stifles immune attack on cancer
A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team led by researchers...
British hospitals face serious shortage of liver specialists
Despite rising rates of alcohol- and obesity-related liver disease, fewer than 1 in 3 UK hospitals employ a full-time liver specialist.
Diabetes drug could be used to combat fatty liver disease, research shows
New research published in The Lancet has shown that a drug, currently used in the treatment of Type II diabetes, can be effective in clearing fatty liver disease from some patients.
Research yields potential treatment approach for glycogen storage disease
Researchers from the Duke-NUS Graduate Medical School Singapore (Duke-NUS) and Duke Medicine have identified a potential treatment strategy for an often-fatal inherited glycogen storage disease.
Bipartisan US report advocates fighting global disease to advance range of American interests
A new US bipartisan study advocates promoting global health to both "do the right thing" and advance wide-ranging foreign policy interests.